Antiresorptive medication-related osteonecrosis of the jaw: Incidence and preventive measures utilization in cancer patients
Introduction: Antiresorptive drugs are commonly used to treat cancer and bone metastases. These drugs can impose the risk of osteonecrosis of the jaw (ONJ). ONJ is a serious complication that can lead to significant morbidity and mortality. This study aimed to investigate the incidence and preventiv...
Saved in:
Main Authors: | Salman Ali Alabdali, Abdulrahman Ali Alabdali, Sultan Qais Alnoaman, Abdullah Abuasida, Saud Balelah, Abdulaziz Almuzaini, Abdullah Homeed Almatrafi, Hossein M. Elbadawy |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-12-01
|
Series: | Saudi Dental Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1013905224003225 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Education and Communication on the Topic of Osteonecrosis of the Jaw When Taking Bone‐Stabilizing Drugs
by: Franz Gustav Saur, et al.
Published: (2024-12-01) -
Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw
by: Han-Jin Ruan, et al.
Published: (2024-12-01) -
Preliminary analysis of incidence, risk factors, and management of medication-related osteonecrosis of the jaw in cancer patients
by: P.J. Nagarathna, et al.
Published: (2024-12-01) -
Torus palatinus osteonecrosis: A hitherto unreported complication of long-term Denosumab use
by: Kendal L. Weger, MD, et al.
Published: (2025-01-01) -
Role of Denosumab and Zoledronic Acid in Geriatric Hip Fractures – A Comparative Analysis
by: P Madhuchandra, et al.
Published: (2024-01-01)